Compare Humana Inc (HUM) vs Visa Inc (V) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Visa Inc — how do they compare? Humana Inc trades at $374.2 (market cap $46.31B), while Visa Inc trades at $362.01 (market cap $668.96B). The key difference: Visa Inc is far larger — about 14.4× Humana Inc's market cap, and Humana Inc pays the higher dividend (0.92%). Which is the better fit depends on your goals.
| HUM | V | |
|---|---|---|
Market Cap | $46.31B | $668.96B |
Sector | Health | Financials |
52-Week High | $409.42 | $370.47 |
52-Week Low | $163.67 | $295.52 |
Enterprise Value | $53.67B | $679.54B |
Dividend Yield | 0.92% | 0.74% |
Volume | — | 10,431,336 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $385.00, up 4.82% today, with a bullish technical outlook and analyst consensus price target of $399.53. Recent earnings beats in Q1 and Q2 2026, alongside revenue growth to $129.66 billion in 2025, support fundamentals, though net margins have compressed. The company is expanding its Medicaid business and targeting margin improvements by 2027.
The stock offers upside to consensus targets but faces risks from Medicare Advantage margin pressures and regulatory changes. Profitability trends are weak despite revenue growth, requiring successful cost management to meet 2028 targets. Institutional sentiment is mixed with a majority hold rating.
Visa (V) trades at $362.55, up 0.01% on the day, with a bullish analyst consensus and strong fundamentals. The stock shows robust profitability with a net income margin of 50.78% and has beaten earnings estimates in recent quarters. Technical indicators are mixed, with a bearish overall signal but bullish moving averages. Recent news highlights Visa's initiatives in AI-powered commerce and stablecoin partnerships, positioning it for future growth amid competitive fintech threats.
The outlook for Visa remains positive due to consistent earnings beats, high profitability, and strategic moves into AI and digital payments. Risks include regulatory pressures and rising competition from fintech. With an average price target of $426.31, Wall Street sees significant upside, but investors should monitor execution on innovation and market share retention.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Visa Inc
Visa Inc. operates a retail electronic payments network and manages global financial services. The Company also offers global commerce through the transfer of value and information among financial institutions, merchants, consumers, businesses, and government entities.
Read more on V →
